PPARγ FL (human recombinant from E coli)

Product Description

Stability : 6 months
Formulation :
A solution in 20 mM Tris HCl, pH 8.0, containing 250 mM KCl, 20% glycerol, 5 mM DTT, and 0.5 mM EDTA
Description :
PPARγ is the most widely studied and has been implicated in the pathology of numerous diseases including obesity, diabetes, atherosclerosis, and cancer. PPARγ is primarily expressed in adipose tissue and to a lesser extent in the colon, immune system, and the retina. The functionality of the DNA binding domain (DBD) was tested using PPARγ Transcription Factor Assay (Catalog no. 10006855). The purity was determined using gel electrophoresis followed by coomassie staining. The ligand binding domain functionality was confirmed using a fluorescent displacement assay with ANS and Rosiglitazone. 
Purity : >90% by SDS-PAGE
Storage : -80°C

Disclaimer: the information on this website is from the internet for reference only. Please refer to the actual instructions attached to the product and the final interpretation is owned by the company.

Send inquiry online For more product information and prices

(Pharmaceutical Ingredients Manufacturer & Supplier & Exporter.)

After sending the online inquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email. —— Green Stone Swiss

Email: sales@raw-pharmaceutical-materials.com
Tel: +86 592 5365887
WhatsApp: +86 189 6515 7632
Send inquiry online: